UCLA Health
At UCLA Health, we provide the best health care, using the latest medical technology — healing humankind one patient at a time.
Oncology
ASH 2022 Conference Coverage
ASH 2022 Once Weekly Selinexor, Carfilzomib & Dexamethasone (XKd) in Triple-Class Refractory MM
FEATURING
Gary Schiller
- 40 views
- December 22, 2022
UCLA Health
Recurrent Cervical Cancer: Updates on Management
FEATURING
Ritu Salani
- 459 views
- April 20, 2022
- 4
UCLA Health
Importance of Thoughtful Testing for PIK3CA Mutations in HR+ MBC
FEATURING
Kelly McCann
- 277 views
- March 14, 2022
- 1
UCLA Health
Impact of Androgen Deprivation Therapy Use and Duration With Definitive Radiotherapy for Localized Prostate Cancer
FEATURING
Amar Kishan
- 319 views
- December 2, 2021
- 1
UCLA Health
ASCO 2021 Highlights on the Outcomes in Patients ≥ 65 Years in the ASCENT Study of Sacituzumab Govitecan in mTNBC
FEATURING
Sara A. Hurvitz
- 82 views
- October 13, 2021
- 1
UCLA Health
ASCO 2021 Updates on Advanced NSCLC: Dose Analysis of the TROP2-Directed ADC Datopotamab Deruxtecan
FEATURING
Aaron Lisberg
- 78 views
- July 6, 2021
UCLA Health
A Case of Stage 3 Distal EAC & ESCC: Considering Pembro+dCRT & Tiragolumab+Atezo After dCRT
FEATURING
Zev A. Wainberg
- 11 views
- May 26, 2021
UCLA Health
2021 Updates on Esophageal Cancer: How Important Is Genomic Profiling? How Does Molecular Landscape Look Like?
FEATURING
Zev A. Wainberg
- 243 views
- May 26, 2021
- 1
UCLA Health
Prostate Cancer PET Imaging Biological Target: FACBC vs PSMA PET/CT - Which Option Should Be the Imaging Modality of Choice in Patients With post-RP early BCR? What Is the Best PET Target for Early Biochemical Recurrence of Prostate Cancer?
FEATURING
Jeremie Calais
- 234 views
- July 15, 2020
UCLA Health
PSMA PET Imaging for Primary Staging: Efficacy Analysis of Methods for Ruling-out N1 and M1b Disease?
FEATURING
Jeremie Calais
- 7 views
- July 15, 2020
UCLA Health
2020 ASCO Update on mCRPC: What Is the OS After 177Lu-PSMA-617 Molecular Radiotherapy?
FEATURING
Jeremie Calais
- 511 views
- June 4, 2020
- 2
UCLA Health
Immunotherapy and Clinical Trials for Brain Tumors
FEATURING
Linda Liau
- 285 views
- January 7, 2020
- 1
UCLA Health
Brain Metastases: Management and Challenging Cases
FEATURING
Won Kim
- 418 views
- January 7, 2020
- 2
UCLA Health
Metastatic Bladder Cancer Beyond Immune Checkpoint Inhibitors: Antibody Drug Conjugates, and Radiation with(out) Anti-PD(L)1
FEATURING
Alexandra Drakaki
- 945 views
- July 10, 2019
- 3
UCLA Health
Metastatic Bladder Cancer Beyond Immune Checkpoint Inhibitors: Chemotherapy Combinations with(out) Anti-PD(L)1
FEATURING
Alexandra Drakaki
- 459 views
- July 10, 2019
- 1